Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Stefan Gravenstein
Advertisement
Stefan Gravenstein is professor of medicine, Brown University and clinical director, quality improvement, at Quality Partners
Articles by Stefan Gravenstein
Advertisement
Latest Updated Articles
Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1Published: January 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
